Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1662-01-7

Post Buying Request

1662-01-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1662-01-7 Usage

Classification

Hole-blocking layer (HBL) materials , Electron injection layer (EIL) materials, OLEDS, Organic photovoltaics, Perovskite solar cells.

Applications

BPhen is widely used as a hole-blocking or exciton-blocking layer due to its wide energy gap and high ionisation potential. The phenanthroline unit is small, rigid, and planar, with extended π-electrons and short hopping lengths that facilitate electron mobility. The electron mobility of BPhen is about 5 × 10-4 cm2 V-1 s-1, which is about two orders of magnitude higher than that of Alq3. When doped with lithium, BPhen:Li is an excellent electron-transport material, and is often used as an electron-injection layer to enable ohmic contact to any electrode -- without the need to consider the work function alignments.

Reactions

Bidentate ligand and reagent for determination of iron. Ligand used in the copper-catalyzed protodecarboxylation of aromatic carboxylic acids.

Description

BPhen is widely used as a hole-blocking or exciton-blocking layer due to its wide energy gap and high ionisation potential.

Chemical Properties

white to faintly yellow crystalline powder

Uses

Different sources of media describe the Uses of 1662-01-7 differently. You can refer to the following data:
1. Bathophenanthroline is widely used for determination of iron in serum and urine by colorimtetry. It acts as buffer layer to improve the efficiency of organic photovoltaic cells. It is very useful as a scavenger reagent, for the removal of traces of iron and copper from reagent solutions, which is used in the trace metal determination. Iron bathophenanthroline complex is involved as a redox mediating agent for imaging surface immobilized deoxyribonucleic acid (DNA) by using Scanning Electrochemical Microscopy (SECM).
2. Bathophenanthroline was used in an ultra-sensitive and selective nonextractive quenchofluorimetric method, in order to determine palladium (II) at μg/l Levels. It may also be used as the buffer layer to improve the performance of organic photovoltaic cells.

Definition

ChEBI: A member of the class of phenanthrolines that is 1,10-phenanthroline bearing two phenyl substituents at positions 4 and 7.

General Description

This product has been enhanced for catalysis.

Check Digit Verification of cas no

The CAS Registry Mumber 1662-01-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,6,6 and 2 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1662-01:
(6*1)+(5*6)+(4*6)+(3*2)+(2*0)+(1*1)=67
67 % 10 = 7
So 1662-01-7 is a valid CAS Registry Number.
InChI:InChI=1/C24H16N2/c1-3-7-17(8-4-1)19-13-15-25-23-21(19)11-12-22-20(14-16-26-24(22)23)18-9-5-2-6-10-18/h1-16H

1662-01-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B2695)  Bathophenanthroline (purified by sublimation)  >99.0%(HPLC)(T)

  • 1662-01-7

  • 1g

  • 1,560.00CNY

  • Detail
  • TCI America

  • (D0905)  Bathophenanthroline  >99.0%(T)

  • 1662-01-7

  • 1g

  • 850.00CNY

  • Detail
  • TCI America

  • (D0905)  Bathophenanthroline  >99.0%(T)

  • 1662-01-7

  • 5g

  • 3,990.00CNY

  • Detail
  • Alfa Aesar

  • (A14258)  Bathophenanthroline, 98+%   

  • 1662-01-7

  • 1g

  • 409.0CNY

  • Detail
  • Alfa Aesar

  • (A14258)  Bathophenanthroline, 98+%   

  • 1662-01-7

  • 5g

  • 1806.0CNY

  • Detail
  • Alfa Aesar

  • (A14258)  Bathophenanthroline, 98+%   

  • 1662-01-7

  • 25g

  • 7779.0CNY

  • Detail
  • Sigma-Aldrich

  • (11880)  Bathophenanthroline  for spectrophotometric det. of Fe in serum, ≥99.0%

  • 1662-01-7

  • 11880-500MG-F

  • 676.26CNY

  • Detail
  • Sigma-Aldrich

  • (11880)  Bathophenanthroline  for spectrophotometric det. of Fe in serum, ≥99.0%

  • 1662-01-7

  • 11880-1G-F

  • 1,138.41CNY

  • Detail
  • Sigma-Aldrich

  • (11880)  Bathophenanthroline  for spectrophotometric det. of Fe in serum, ≥99.0%

  • 1662-01-7

  • 11880-5G-F

  • 4,520.88CNY

  • Detail
  • Aldrich

  • (133159)  Bathophenanthroline  97%

  • 1662-01-7

  • 133159-500MG

  • 912.60CNY

  • Detail
  • Aldrich

  • (133159)  Bathophenanthroline  97%

  • 1662-01-7

  • 133159-1G

  • 1,525.68CNY

  • Detail

1662-01-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 4,7-diphenyl-1,10-phenanthroline

1.2 Other means of identification

Product number -
Other names bathophenanthrolin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1662-01-7 SDS

1662-01-7Synthetic route

3-chloropropiophenone
936-59-4

3-chloropropiophenone

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

bathophenanthroline
1662-01-7

bathophenanthroline

Conditions
ConditionsYield
With hydrogenchloride; hydrogen iodide In water at 100℃; for 0.333333h; Reagent/catalyst; Temperature;76.4%
4-phenyl-8-aminoquinoline
55484-55-4

4-phenyl-8-aminoquinoline

3-chloropropiophenone
936-59-4

3-chloropropiophenone

bathophenanthroline
1662-01-7

bathophenanthroline

Conditions
ConditionsYield
With phosphoric acid; orthoarsenic acid
3-chloropropiophenone
936-59-4

3-chloropropiophenone

bathophenanthroline
1662-01-7

bathophenanthroline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: arsenic acid; aqueous sulfuric acid
2: SnCl2+2 H2O; ethanol
3: syrupy H3PO4; H3aso4
View Scheme
4-phenyl-8-nitroquinoline
25771-65-7

4-phenyl-8-nitroquinoline

bathophenanthroline
1662-01-7

bathophenanthroline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: SnCl2+2 H2O; ethanol
2: syrupy H3PO4; H3aso4
View Scheme
2-nitro-aniline
88-74-4

2-nitro-aniline

bathophenanthroline
1662-01-7

bathophenanthroline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: arsenic acid; aqueous sulfuric acid
2: SnCl2+2 H2O; ethanol
3: syrupy H3PO4; H3aso4
View Scheme
[Co(4,7-diphenyl-1,10-phenanthroline)2(diflunisal)][hexafluorophosphate]

[Co(4,7-diphenyl-1,10-phenanthroline)2(diflunisal)][hexafluorophosphate]

A

bathophenanthroline
1662-01-7

bathophenanthroline

B

2',4'-difluoro-4-hydroxybiphenyl-3-carboxylic acid
22494-42-4

2',4'-difluoro-4-hydroxybiphenyl-3-carboxylic acid

Conditions
ConditionsYield
In aq. phosphate buffer at 37℃; for 24h; Time;
bis-(dimethyl(phenyl)silylmethyl)(cycloocta-1,5-diene)platinum(II)

bis-(dimethyl(phenyl)silylmethyl)(cycloocta-1,5-diene)platinum(II)

bathophenanthroline
1662-01-7

bathophenanthroline

bis-(dimethyl(phenyl)silylmethyl)(4,7-diphenyl-1,10-phenanthroline)platinum(II)

bis-(dimethyl(phenyl)silylmethyl)(4,7-diphenyl-1,10-phenanthroline)platinum(II)

Conditions
ConditionsYield
In toluene Ar atmosphere; stirring (60°C, 28 d); removal of excess of ligand on washing with aq. FeSO4, concn., pptn. on addn. of hexane; elem. anal.;99%
bis(triphenylphosphino)copper(I) nitrate
14494-93-0, 23751-62-4, 106678-35-7

bis(triphenylphosphino)copper(I) nitrate

bathophenanthroline
1662-01-7

bathophenanthroline

triphenylphosphine
603-35-0

triphenylphosphine

(4,7-diphenyl-1,10-phenanthroline)bis(triphenylphosphine)copper(I) nitrate
1262033-35-1

(4,7-diphenyl-1,10-phenanthroline)bis(triphenylphosphine)copper(I) nitrate

Conditions
ConditionsYield
In chloroform at 20℃; for 1h; Schlenk technique;99%
bathophenanthroline
1662-01-7

bathophenanthroline

2-methyl-4,7-diphenyl-1,10-phenanthroline

2-methyl-4,7-diphenyl-1,10-phenanthroline

Conditions
ConditionsYield
With methyllithium In tetrahydrofuran at 0℃; for 0.25h; Inert atmosphere;99%
MoO2Br2(NCCH3)2

MoO2Br2(NCCH3)2

bathophenanthroline
1662-01-7

bathophenanthroline

((C6H5)2C12H6N2)MoO2(Br)2

((C6H5)2C12H6N2)MoO2(Br)2

Conditions
ConditionsYield
In tetrahydrofuran N2; stirred for 1 h; cncd., pptd. (ether), ppt. washed (diethyl ether), dried (vac.); elem. anal.;98%
bathophenanthroline
1662-01-7

bathophenanthroline

chromium(III) chloride
10025-73-7

chromium(III) chloride

[(4,7-diphenyl-1,10-phenanthroline)2CrCl2]Cl
1242583-98-7

[(4,7-diphenyl-1,10-phenanthroline)2CrCl2]Cl

Conditions
ConditionsYield
With Zn In ethanol solid anhyd. CrCl3 was added to a suspn. of phenanthroline-compound in abs. ethanol, a trace amount of zinc dust was added, the mixt. was heatedto reflux for 1 h; filtered, rotary evapd.;98%
bathophenanthroline
1662-01-7

bathophenanthroline

[(η5-C5H4CH2C6H4Br-4)Mo(CO)2(NCMe)2][BF4]

[(η5-C5H4CH2C6H4Br-4)Mo(CO)2(NCMe)2][BF4]

[(η5-C5H4CH2C6H4Br-4)Mo(CO)2(4,7-Ph2-phen)][BF4]

[(η5-C5H4CH2C6H4Br-4)Mo(CO)2(4,7-Ph2-phen)][BF4]

Conditions
ConditionsYield
In dichloromethane at 20℃; Inert atmosphere; Schlenk technique;98%
silver tetrafluoroborate
14104-20-2

silver tetrafluoroborate

bathophenanthroline
1662-01-7

bathophenanthroline

1,3-bis-(diphenylphosphino)propane
6737-42-4

1,3-bis-(diphenylphosphino)propane

[Ag2(4,7-diphenyl-1,10-phenanthroline)2(μ-1,3-bis(diphenylphosphino)propane)](BF4)2

[Ag2(4,7-diphenyl-1,10-phenanthroline)2(μ-1,3-bis(diphenylphosphino)propane)](BF4)2

Conditions
ConditionsYield
Stage #1: silver tetrafluoroborate; 1,3-bis-(diphenylphosphino)propane In methanol; dichloromethane for 1h; Inert atmosphere; Schlenk technique;
Stage #2: bathophenanthroline In methanol; dichloromethane for 1h; Inert atmosphere; Schlenk technique;
97%
dichloro(benzene)ruthenium(II) dimer
37366-09-9

dichloro(benzene)ruthenium(II) dimer

bathophenanthroline
1662-01-7

bathophenanthroline

[(BZ)(Ph2phen)RuCl]Cl

[(BZ)(Ph2phen)RuCl]Cl

Conditions
ConditionsYield
In methanol for 3.25h; Inert atmosphere; Reflux;97%
In water for 0.25h; Sonication; Green chemistry;
bathophenanthroline
1662-01-7

bathophenanthroline

[(η5-C5H4CH2C6H4F-4)Mo(CO)2(NCMe)2][BF4]

[(η5-C5H4CH2C6H4F-4)Mo(CO)2(NCMe)2][BF4]

[(η5-C5H4CH2C6H4F-4)Mo(CO)2(4,7-Ph2-phen)][BF4]

[(η5-C5H4CH2C6H4F-4)Mo(CO)2(4,7-Ph2-phen)][BF4]

Conditions
ConditionsYield
In dichloromethane at 20℃; Inert atmosphere; Schlenk technique;97%
bathophenanthroline
1662-01-7

bathophenanthroline

diethylzinc
557-20-0

diethylzinc

C28H26N2Zn

C28H26N2Zn

Conditions
ConditionsYield
for 1h; Inert atmosphere; Schlenk technique; Glovebox;97%
bis(pentafluorophenyl)(1,5-cyclooctadiene)platinum(II)

bis(pentafluorophenyl)(1,5-cyclooctadiene)platinum(II)

bathophenanthroline
1662-01-7

bathophenanthroline

(4,7-diphenylphenanthroline)Pt(C6F5)2
852954-53-1

(4,7-diphenylphenanthroline)Pt(C6F5)2

Conditions
ConditionsYield
recrystn. and subl.;96%
copper(II) choride dihydrate

copper(II) choride dihydrate

bathophenanthroline
1662-01-7

bathophenanthroline

(2S)-2-(6-methoxy(2-naphthyl))propanoic acid
22204-53-1

(2S)-2-(6-methoxy(2-naphthyl))propanoic acid

Cu(4,7-diphenyl-1,10-phenanthroline)(naproxen)2

Cu(4,7-diphenyl-1,10-phenanthroline)(naproxen)2

Conditions
ConditionsYield
Stage #1: (2S)-2-(6-methoxy(2-naphthyl))propanoic acid With potassium hydroxide In methanol at 20℃; for 1h;
Stage #2: copper(II) choride dihydrate; bathophenanthroline In methanol at 50℃; for 20h;
96%
tetrakis(actonitrile)copper(I) hexafluorophosphate
64443-05-6

tetrakis(actonitrile)copper(I) hexafluorophosphate

bathophenanthroline
1662-01-7

bathophenanthroline

bis[2-(diphenylphosphino)phenyl] ether
166330-10-5

bis[2-(diphenylphosphino)phenyl] ether

C60H44CuN2OP2(1+)*F6P(1-)
1421057-29-5

C60H44CuN2OP2(1+)*F6P(1-)

Conditions
ConditionsYield
Stage #1: tetrakis(actonitrile)copper(I) hexafluorophosphate; bis[2-(diphenylphosphino)phenyl] ether In dichloromethane Schlenk technique; Reflux;
Stage #2: bathophenanthroline In dichloromethane at 20℃; Schlenk technique; Reflux;
95%
bathophenanthroline
1662-01-7

bathophenanthroline

dichlorido(4,7-diphenyl-1,10-phenanthroline)platinum(II)
35273-41-7

dichlorido(4,7-diphenyl-1,10-phenanthroline)platinum(II)

Conditions
ConditionsYield
In methanol for 3h; Reflux;95%
copper(II) choride dihydrate

copper(II) choride dihydrate

diethyl ether
60-29-7

diethyl ether

bathophenanthroline
1662-01-7

bathophenanthroline

(S,S)-1,2-diaminocyclohexane
21436-03-3

(S,S)-1,2-diaminocyclohexane

potassium perchlorate

potassium perchlorate

[copper(II)((1S,2S)-diaminocyclohexane)(4,7-diphenyl-1,10-phenanthroline)](perchlorate)2*0.5(C4H10O)

[copper(II)((1S,2S)-diaminocyclohexane)(4,7-diphenyl-1,10-phenanthroline)](perchlorate)2*0.5(C4H10O)

Conditions
ConditionsYield
In ethanol; water at 60℃; for 3.5h;94%
(tetra-n-butylammonium)2[Mo3S7Cl6]

(tetra-n-butylammonium)2[Mo3S7Cl6]

bathophenanthroline
1662-01-7

bathophenanthroline

Mo3S7Cl4(4,7-diphenyl-1,10-phenanthroline)

Mo3S7Cl4(4,7-diphenyl-1,10-phenanthroline)

Conditions
ConditionsYield
In dichloromethane at 20℃; for 6.5h; Reflux;94%
bathophenanthroline
1662-01-7

bathophenanthroline

methyllithium
917-54-4

methyllithium

2-methyl-4,7-diphenyl-1,10-phenanthroline

2-methyl-4,7-diphenyl-1,10-phenanthroline

Conditions
ConditionsYield
In diethyl ether; toluene at 0 - 20℃; for 1h; Schlenk technique; Inert atmosphere;94%
In diethyl ether; toluene at 0℃; for 0.5h;63%
In diethyl ether; toluene at 0℃; for 0.5h; Inert atmosphere; Schlenk technique;55%
uranyl nirate hexahydrate

uranyl nirate hexahydrate

bathophenanthroline
1662-01-7

bathophenanthroline

[UVIO2(NO3)2(4,7-diphenyl-1,10-phenanthroline)]

[UVIO2(NO3)2(4,7-diphenyl-1,10-phenanthroline)]

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;94%
tetrakis(acetonitrile)copper(I)tetrafluoroborate

tetrakis(acetonitrile)copper(I)tetrafluoroborate

bathophenanthroline
1662-01-7

bathophenanthroline

bis(diphenylphosphino)acetylene
5112-95-8

bis(diphenylphosphino)acetylene

benzene
71-43-2

benzene

C100H72Cu2N4P4(2+)*2BF4(1-)*C6H6

C100H72Cu2N4P4(2+)*2BF4(1-)*C6H6

Conditions
ConditionsYield
Stage #1: tetrakis(acetonitrile)copper(I)tetrafluoroborate; bis(diphenylphosphino)acetylene In dichloromethane; acetonitrile for 0.5h; Inert atmosphere;
Stage #2: bathophenanthroline In dichloromethane; acetonitrile for 1h; Inert atmosphere;
Stage #3: benzene In diethyl ether at -100.16℃;
94%
tetrakis(acetonitrile)copper(I)tetrafluoroborate

tetrakis(acetonitrile)copper(I)tetrafluoroborate

bathophenanthroline
1662-01-7

bathophenanthroline

bis(diphenylphosphino)acetylene
5112-95-8

bis(diphenylphosphino)acetylene

[Cu2(μ-dppa)2(bathophenanthroline)2](BF4)2

[Cu2(μ-dppa)2(bathophenanthroline)2](BF4)2

Conditions
ConditionsYield
Stage #1: tetrakis(acetonitrile)copper(I)tetrafluoroborate; bis(diphenylphosphino)acetylene In dichloromethane; acetonitrile for 0.5h; Inert atmosphere;
Stage #2: bathophenanthroline In dichloromethane; acetonitrile for 1h; Inert atmosphere;
94%
bathophenanthroline
1662-01-7

bathophenanthroline

palladium diacetate
3375-31-3

palladium diacetate

(4,7-diphenyl-1,10-phenanthroline)palladium(II) acetate
95246-09-6

(4,7-diphenyl-1,10-phenanthroline)palladium(II) acetate

Conditions
ConditionsYield
In dichloromethane; toluene at 20℃; Inert atmosphere;93%
In dichloromethane; toluene at 20℃; Inert atmosphere;93%
With CH3COOH In acetone (Pd(MeCOO)2) is dissolved in acetone at room temp., after 30 min soln. is filtd. and a few drops of glacial acetic acid are added, the ligand is added as a solid to the soln.; ppt. is filtd., washed with cold acetone and dried in vac., elem. anal.;70%
bathophenanthroline
1662-01-7

bathophenanthroline

1,3-dibromo-propane
109-64-8

1,3-dibromo-propane

2Br(1-)*C27H22N2(2+)

2Br(1-)*C27H22N2(2+)

Conditions
ConditionsYield
at 130℃; for 6h; Inert atmosphere;93%
In nitrobenzene Menschutkin reaction;
With oxygen for 0.5h; Reflux;
In toluene Reflux;
ethanol
64-17-5

ethanol

Eu2(Piv)6(HPiv)6*HPiv

Eu2(Piv)6(HPiv)6*HPiv

bathophenanthroline
1662-01-7

bathophenanthroline

[(4,7-diphenyl-1,10-phenanthroline)2Eu2(piv)6]*2EtOH

[(4,7-diphenyl-1,10-phenanthroline)2Eu2(piv)6]*2EtOH

Conditions
ConditionsYield
In ethanol EtOH added to 4,7-Ph2-1,10-phen and Eu complex, heated at 80°C; filtered, concd.(vac.) at room temp., kept at 20°C for 24 h, washed (cold EtOH), dried (air), elem. anal.;93%
With air at 80℃; Schlenk technique;53%
[{η5-C5H4(C5F4N)}Mo(CO)2(NCMe)2][BF4]

[{η5-C5H4(C5F4N)}Mo(CO)2(NCMe)2][BF4]

bathophenanthroline
1662-01-7

bathophenanthroline

[{η5-C5H4(C5F4N)}Mo(CO)2(4,7-diphenyl-1,10-phenanthroline)][BF4]

[{η5-C5H4(C5F4N)}Mo(CO)2(4,7-diphenyl-1,10-phenanthroline)][BF4]

Conditions
ConditionsYield
In dichloromethane at 20℃; for 16h;93%
bathophenanthroline
1662-01-7

bathophenanthroline

[(η5-C5H4CH2C6H4Cl-4)Mo(CO)2(NCMe)2][BF4]

[(η5-C5H4CH2C6H4Cl-4)Mo(CO)2(NCMe)2][BF4]

[(η5-C5H4CH2C6H4Cl-4)Mo(CO)2(4,7-Ph2-phen)][BF4]

[(η5-C5H4CH2C6H4Cl-4)Mo(CO)2(4,7-Ph2-phen)][BF4]

Conditions
ConditionsYield
In dichloromethane at 20℃; Inert atmosphere; Schlenk technique;93%
5,7-dihydroxy-2-phenyl-chromen-4-one
480-40-0

5,7-dihydroxy-2-phenyl-chromen-4-one

bathophenanthroline
1662-01-7

bathophenanthroline

C39H25CuN2O4(1+)*ClO4(1-)

C39H25CuN2O4(1+)*ClO4(1-)

Conditions
ConditionsYield
Stage #1: copper(II) perchlorate hexahydrate; 5,7-dihydroxy-2-phenyl-chromen-4-one In methanol at 20℃; for 0.5h;
Stage #2: bathophenanthroline In methanol at 20℃; for 2h;
93%
cis-bis{(trimethylsilyl)methyl}(1,5-cyclooctadiene)platinum(II)
36223-69-5

cis-bis{(trimethylsilyl)methyl}(1,5-cyclooctadiene)platinum(II)

bathophenanthroline
1662-01-7

bathophenanthroline

bis(trimethylsilylmethyl)(4,7-diphenyl-1,10-phenanthroline)platinum(II)

bis(trimethylsilylmethyl)(4,7-diphenyl-1,10-phenanthroline)platinum(II)

Conditions
ConditionsYield
In toluene under Ar, heated to 60°C for 14 days; extn. (aq. ferrous sulphate soln.), organic phase concd., addn. of n-hexane, cooled, washed with hexane; elem. anal.;92%

1662-01-7Related news

Aggregation of non-amphiphilic Bathophenanthroline (cas 1662-01-7) in the restricted geometry of Langmuir–Blodgett films with two different matrices09/25/2019

The behavior of binary mixed Langmuir monolayers from the mixture of non-amphiphilic bathophenanthroline (BPH) and behenic acid (BA)/poly(methyl methacrylate) (PMMA) spread on aqueous subphase was investigated on the basis of the analysis of surface pressure–average area per molecule (π–A) is...detailed

Short communicationEffects of a Bathophenanthroline (cas 1662-01-7) exciton blocking layer on thermal annealing-free bulk heterojunction solar cells09/24/2019

The effects of bathophenanthroline (Bphen) as an exciton blocking layer (EBL) on annealing-free bulk heterojunction solar cells were investigate. A nonannealed donor–acceptor conjugated polymer was employed as the donor to ensure the simplicity of device fabrication and good reproducibility of ...detailed

Synthesis, structure, theoretical studies and luminescent properties of a ternary erbium(III) complex with acetylacetone and Bathophenanthroline (cas 1662-01-7) ligands09/10/2019

A novel erbium(III) complex with acetylacetone (Hacac) and bathophenanthroline (4,7-diphenyl-1,10-phenanthroline, bath) ligands, formulated as [Er(acac)3(bath)], has been characterized by elemental analysis, X-ray diffraction, thermogravimetric analysis, Fourier transform infrared spectroscopy, ...detailed

Synthesis and photoluminescence properties of asymmetrical europium(III) complexes involving carbazole, phenanthroline and Bathophenanthroline (cas 1662-01-7) units09/09/2019

Three novel europium complexes, Eu(CCHPD)3Phen = Tris[1-(9H-carbazol-9-yl)-3-[(6-(9H- carbazol-9-yl)hexoxy)-phenyl]-1,3-dione](1,10-phenanthroline) europium(III), Eu(CCHPD)3Bath = Tris[1-(9H-carbazol-9-yl)-3-[(6-(9H-carbazol-9-yl)hexoxy)-phenyl]-1,3-dione](bathophenanthroline) europium(III) and ...detailed

Short communicationEffect of charge carrier behaviours in LiF-doped Bathophenanthroline (cas 1662-01-7) (LiF:Bphen) on the performance of organic light-emitting diodes09/08/2019

Charge carrier behaviours of LiF-doped bathophenanthroline (LiF:Bphen) were investigated by single carrier devices: electron-only and hole-only devices. The results indicate that LiF doped with Bphen has dual roles: increasing current density due to enhanced electron injection and transport; dec...detailed

1662-01-7Relevant articles and documents

Diflunisal-adjoined cobalt(iii)-polypyridyl complexes as anti-cancer stem cell agents

Abe, David O.,Eskandari, Arvin,Suntharalingam, Kogularamanan

, p. 13761 - 13765 (2018)

We report a novel series of cobalt(iii)-polypridyl complexes, 4-6, that can selectively release diflunisal, a nonsteroidal anti-inflammatory drug, under reducing conditions. Remarkably, the 1,10-phenanthroline-bearing complex 5 displays selective potency towards hard-to-kill cancer stem cells (CSCs) (IC50 = 2.1 ± 0.1 μM) over bulk cancer (IC50 = 3.9 ± 0.2 μM) and normal cells (IC50 = 21.2 ± 1.3 μM). This complex induces CSC apoptosis by DNA damage and cyclooxygenase-2 inhibition.

Synthesizing method of 4,7-diphenyl-1,10-o-phenanthroline

-

Paragraph 0025; 0026; 0027; 0028-0034, (2019/03/28)

The invention provides a preparation method of 4,7-diphenyl-1,10-o-phenanthroline (I). The preparation method comprises the following steps of pumping a mixed acid solution of 3-chloropropiophenone (II) and o-phenylenediamine (III) into a micro-channel reactor, heating to certain reaction temperature, reacting for a period of time, cooling and filtering the reaction liquid flowing out, neutralizing filter cake by ammonia water, rinsing, and then filtering, so as to obtain the 4,7-diphenyl-1,10-o-phenanthroline. The preparation method has the advantages that by adopting the micro-channel reaction technology, the continuous production of 4,7-diphenyl-1,10-o-phenanthroline is realized; the safety and stability of the technology are high, the operation is simple, and the scale amplification and industrialized production are convenient. The structural formula of the 4,7-diphenyl-1,10-o-phenanthroline is shown in the description.

Catalyst compositions and a process for polymerizing carbon monoxide and olefins

-

, (2008/06/13)

Carbon monoxide and at least one olefinically unsaturated organic compound may be polymerized by contacting the monomers in the presence of a catalyst which comprises a Group VIII metal compound of palladium, cobalt or nickel, a halide of tin or germanium, a nitrogen bidentate ligand and an organic oxidant. The polymers prepared are linear alternating polymers which consist of units with the formula STR1 where A is the residue of an alkenically unsaturated organic compound monomer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1662-01-7